デオキシリボニル酸（DNA）ポリメラーゼ市場調査レポート-最新動向、成長機会、市場規模およびシェア世界予測分析-2024年～2033年

Deoxyribonucleic Acid (DNA) Polymerase Market Size Research Report - Inzaglance

According to a research report on the global deoxyribonucleic acid (DNA) polymerase market , the market is projected to grow at a CAGR of 1.3% between 2024 and 2033, and is further projected to generate a market size of USD 152.8 million by the end of 2033. In 2024, the market size was USD 137.0 million .

• The global deoxyribonucleic acid (DNA) polymerase market is expected to grow due to the surge in chronic diseases.
• In Japan, the growth of the DNA polymerase market is attributed to advances in research in genomics and related fields.
• KDMI analyst growth analysis predicts that rising costs of DNA polymerases will pose a challenge to market growth.
• North America, with the highest market share in the deoxyribonucleic acid (DNA) polymerase market, is expected to dominate the global market

Deoxyribonucleic Acid (DNA) Polymerase Market Analysis

DNA polymerase is an enzyme that helps in copying DNA (deoxyribonucleic acid) and building new strands by joining small pieces of nucleotides that complement the original strand. This process is also essential for cell replication and DNA maintenance, ensuring accuracy by checking the newly made DNA for errors. In recent years, the DNA polymerase market has a huge room for expansion due to the sharp increase in chronic diseases. According to the latest report, around 1.8 million adults worldwide are more likely to suffer from serious diseases such as type 2 diabetes, heart disease, and some cancers due to lack of physical activity. Therefore, the increase in the production of recombinant medicines for the treatment of chronic diseases will ultimately drive the growth of the DNA polymerase market. Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories Inc. are some of the key players in the global deoxyribonucleic acid (DNA) polymerase market.

Analysts' views on Japan Deoxyribonucleic Acid (DNA) Polymerase Market Research

One of the major factors driving the expansion of the DNA polymerase market in Japan is the advancement of research in genomics and related fields. For a long time, Japan has been home to a thriving scientific community and has significantly shaped the field of genetics with numerous innovative discoveries. With increasing awareness of the genetic causes of diseases, genetic disorders are receiving more attention in medical research. Certain genetic disorders have been found to appear more frequently than usual, resulting in an incidence rate of approximately 1 in 100 newborns in Japan. This has led to an increased need for early detection and accurate diagnosis, which has led to the flourishing of genomic research, driving the DNA polymerase market. Takara Bio Inc., Toyobo Co., Ltd., Illumina Inc. Major players in the deoxyribonylic acid (DNA) polymerase market in Japan are Takara Bio Inc., Toyobo Co., Ltd., Illumina Inc., etc.

Deoxyribonucleic Acid (DNA) Polymerase Market Growth Drivers and Challenges

Growth Drivers

Advances in personalized treatment:

Personalized medicine is gradually breaking the limitations of traditional medicine. Simply put, it is tailor-made treatment according to the unique genetic profile of each individual. In today's 21st century world, groundbreaking advancements are paving the way for a more personalized approach. The future of personalized medicine is full of opportunities to revolutionize healthcare. And DNA polymerase is at the core of personalized medicine owing to its accurate genetic analysis, sequencing, and diagnostic capabilities. Thus, the growth of the tailored therapy field is propelling the DNA polymerase market forward by expanding the demand for personalized treatments and medicines, which ultimately steers the DNA polymerase market. Moreover, the pharmaceutical industry is predicted to pivot completely towards personalized treatments, thereby propelling the market.

Increasing demand for molecular diagnostics

The growing need for timely diagnosis has led to a boom in molecular diagnostics, which is primarily related to RNA and DNA mutations. In molecular diagnostics, DNA polymerases help in the recognition and replication of target DNA sequences. Due to their ability to generate new DNA strands, DNA polymerases are widely used in PCR (polymerase chain reaction). As genetic and infectious diseases become increasingly prevalent, the demand for these polymerases and related diagnostic tests is also expected to increase. According to a new report by the World Health Organization (WHO), approximately 8.2 million new cases of tuberculosis will be diagnosed in 2023. This surge in molecular diagnostic tests is therefore driving the growth of the DNA polymerase market on a global scale.

Obstacles

Rising costs of DNA polymerase:

New technologies are usually based on expensive enzymes, which poses a major challenge for the global market. In biotechnology, the latest technologies have a major impact on the price of DNA polymerases. Hence, the rising trend in the cost of DNA polymerases is acting as an obstacle for the market growth.

Inadequate government funding:

Without financial backing, it is difficult for companies and research institutes to develop and improve polymerase-based diagnostic solutions. Moreover, it also creates challenges for smaller companies, limiting market entry and slowing down the expansion of the industry. Therefore, inadequate or lack of government funding will stifle research and development activities, severely hindering the DNA polymerase market.

Deoxyribonucleic Acid (DNA) Polymerase Market Segmentation

Experts at KD Market Insights have segmented the global Deoxyribonucleic Acid (DNA) Polymerase market research report into:

Deoxyribonucleic Acid (DNA) Polymerase Market Overview by Region

North America holds the largest share of the global deoxyribonucleic acid (DNA) polymerase market. This is mainly due to the increasing spending on molecular diagnostics in the region. Moreover, the growth of this regional market is further driven by the presence of major biotechnology production companies, outsourced production plants, rapid growth in the elderly population, growing need for personalized and correct treatment, and chronic diseases like genetic disorders and cancer. The United States holds the largest share of the North American DNA polymerase market due to its strong economic structure and huge investments in research and development in the field of molecular biology. According to statistics from the Organization for Economic Cooperation and Development (OECD), the country's dominance in research and development is clear with the total domestic spending on research and development being $806 million in 2021.

Asia Pacific (APAC) is expected to be the fastest growing region in the DNA polymerase market. China is leading the DNA polymerase market share during the forecast period. Public-private collaboration is driving technological advancements, helping the country continue to lead the market. Apart from China, lower-growth countries such as Japan, India, South Korea, and Australia are also driving the market. The growing use of genetic testing and rising demand for top-quality diagnostic solutions are also further enhancing India's position in the global market. However, the region has the world's largest aging population, which is plagued by a number of diseases, which are also driving the market growth.

The market is expected to grow in Europe, primarily due to the increasing incidence of genetic and infectious diseases. The region is also seeing a strong emphasis on personalized treatments generated by PCR technology, further boosting the market growth. Moreover, the increasing use of PCR in infectious disease detection and food safety is also stimulating the DNA polymerase market over a period of time. Moreover, growing awareness among patients and advancements in the medical field are other key growth drivers for this regional market.

According to analysts at KD Market Insights, five companies are leading the growth of the North American DNA polymerase market:

• Thermo Fisher Scientific Inc.
• QIAGEN
• Illumina Inc.
• Danaher
• Merck KGaA,

Deoxyribonucleic Acid (DNA) Polymerase Market Competitive Landscape

Some of the major players holding the top market share in the global Deoxyribonucleic Acid (DNA) Polymerase market are:

• Thermo Fisher Scientific Inc.
• Hoffmann-La Roche AG
• Merck KGaA
• Qiagen NV
• Agilent Technologies Inc.
• Takara Bio Inc.
• Genescript,
• Illumina Inc.
• New England Biolabs, Inc.
• Bioline
• Promega Corporation